Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
Insiders Menu
Roster
Transactions
Atea Pharmaceuticals, Inc. (AVIR)
Date
Name
Title
Type
Security
Shares
Price
Value
Ownership
Reported
11/14/2022
BERGER FRANKLIN M
Director
Sale
Common Stock
16.2k
$5.16
$83.4k
11/11/2022
11/11/2022
BERGER FRANKLIN M
Director
Sale
Common Stock
25.5k
$5.15
$131.3k
11/11/2022
06/17/2022
BERGER FRANKLIN M
Director
Grant
Stock Option (Right to Buy)
61.3k
$6.50
$398.2k
06/17/2022
06/17/2022
Polsky Bruce
Director
Grant
Stock Option (Right to Buy)
61.3k
$6.50
$398.2k
06/17/2022
06/17/2022
Duncan Barbara Gayle
Director
Grant
Stock Option (Right to Buy)
61.3k
$6.50
$398.2k
06/17/2022
06/17/2022
Murphy Polly A.
Director
Grant
Stock Option (Right to Buy)
61.3k
$6.50
$398.2k
06/17/2022
06/17/2022
Lucidi Bruno
Director
Grant
Stock Option (Right to Buy)
61.3k
$6.50
$398.2k
06/17/2022
06/17/2022
Adams Jerome M.
Director
Grant
Stock Option (Right to Buy)
61.3k
$6.50
$398.2k
06/17/2022
01/31/2022
Vavricka John
Chief Commercial Officer
Grant
Stock Option (Right to Buy)
135k
$7.14
$963.9k
01/31/2022
01/31/2022
Hammond Janet MJ
Chief Development Officer
Grant
Stock Option (Right to Buy)
190k
$7.14
$1.4M
01/31/2022
01/31/2022
Horga Maria Arantxa
Chief Medical Officer
Grant
Stock Option (Right to Buy)
170k
$7.14
$1.2M
01/31/2022
01/31/2022
Corcoran Andrea
See Remarks
Grant
Stock Option (Right to Buy)
181k
$7.14
$1.3M
01/31/2022
01/31/2022
Foster Wayne
EVP, Chief Accounting Officer
Grant
Stock Option (Right to Buy)
120k
$7.14
$856.8k
01/31/2022
01/31/2022
Sommadossi Jean-Pierre
President, CEO, and Chairman
Grant
Stock Option (Right to Buy)
378k
$7.14
$2.7M
01/31/2022
12/20/2021
Murphy Polly A.
Director
Purchase
Common Stock
12k
$8.57
$102.8k
12/20/2021
06/18/2021
Duncan Barbara Gayle
Director
Grant
Stock Option (Right to Buy)
34k
$23.39
$795.8k
06/18/2021
06/18/2021
Murphy Polly A.
Director
Grant
Stock Option (Right to Buy)
34k
$23.39
$795.8k
06/18/2021
06/18/2021
Lucidi Bruno
Director
Grant
Stock Option (Right to Buy)
34k
$23.39
$795.8k
06/18/2021
06/18/2021
Polsky Bruce
Director
Grant
Stock Option (Right to Buy)
34k
$23.39
$795.8k
06/18/2021
06/18/2021
BERGER FRANKLIN M
Director
Grant
Stock Option (Right to Buy)
34k
$23.39
$795.8k
06/18/2021
05/18/2021
Adams Jerome M.
Director
Grant
Stock Option (Right to Buy)
56.7k
$23.43
$1.3M
05/18/2021
01/29/2021
Vavricka John
Chief Commercial Officer
Grant
Stock Option (Right to Buy)
117.3k
$73.00
$8.6M
01/29/2021
01/29/2021
Horga Maria Arantxa
Chief Medical Officer
Grant
Stock Option (Right to Buy)
145.5k
$73.00
$10.6M
01/29/2021
01/29/2021
Hammond Janet MJ
Chief Development Officer
Grant
Stock Option (Right to Buy)
160k
$73.00
$11.7M
01/29/2021
01/29/2021
Foster Wayne
EVP, Chief Accounting Officer
Grant
Stock Option (Right to Buy)
71.8k
$73.00
$5.2M
01/29/2021
01/29/2021
Sommadossi Jean-Pierre
President, CEO, and Chairman
Grant
Stock Option (Right to Buy)
640k
$73.00
$46.7M
01/29/2021
01/29/2021
Corcoran Andrea
See Remarks
Grant
Stock Option (Right to Buy)
148.8k
$73.00
$10.9M
01/29/2021
11/03/2020
Rock Springs Capital Management LP
10% Owner
Conversion
Common Stock
1.4M
$0.00
$0
See Footnote
11/03/2020
11/03/2020
Rock Springs Capital Management LP
10% Owner
Conversion
Common Stock
282.4k
$0.00
$0
See Footnote
11/03/2020
11/03/2020
Rock Springs Capital Management LP
10% Owner
Purchase
Common Stock
242.7k
$24.00
$5.8M
See Footnote
11/03/2020
11/03/2020
Rock Springs Capital Management LP
10% Owner
Purchase
Common Stock
7.3k
$24.00
$175k
See Footnote
11/03/2020
11/03/2020
Rock Springs Capital Management LP
10% Owner
Conversion
Series D Convertible Preferred Stock
890.3k
$0.00
$0
See Footnote
11/03/2020
11/03/2020
Rock Springs Capital Management LP
10% Owner
Conversion
Series D-1 Convertible Preferred Stock
521.7k
$0.00
$0
See Footnote
11/03/2020
11/03/2020
Rock Springs Capital Management LP
10% Owner
Conversion
Series D Convertible Preferred Stock
178.1k
$0.00
$0
See Footnote
11/03/2020
11/03/2020
Rock Springs Capital Management LP
10% Owner
Conversion
Series D-1 Convertible Preferred Stock
104.3k
$0.00
$0
See Footnote
11/03/2020
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy